cephalosporin c has been researched along with clavulanic acid in 159 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (20.75) | 18.7374 |
| 1990's | 40 (25.16) | 18.2507 |
| 2000's | 53 (33.33) | 29.6817 |
| 2010's | 27 (16.98) | 24.3611 |
| 2020's | 6 (3.77) | 2.80 |
| Authors | Studies |
|---|---|
| Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
| Faro, S | 1 |
| Griggs, DJ; Piddock, LJ; Traynor, EA | 1 |
| Hohl, P; von Graevenitz, A; Zollinger-Iten, J | 1 |
| Ben Yaghlane-Bouslama, H; Boujnah, A; Kallel, H; Labia, R; Petit, A; Sirot, J; Sofer, L | 1 |
| Aspinall, S; Corkill, JE; Hart, CA; McLennan, AG | 1 |
| Castillo, AM; Gutierrez, J; Liebana, J; Martin, MA; Piédrola, G | 1 |
| Fass, RJ | 1 |
| Amyes, SG; Marriott, MS; Payne, DJ | 1 |
| Aldridge, KE; Sanders, CV | 1 |
| Giroir, AM; Grosset, J; Jarlier, V; Nicolas, MH; Philippon, A | 1 |
| Chan, RK; Thirumoorthy, T | 1 |
| Rice, RJ; Thompson, SE | 1 |
| McDougal, LK; Thornsberry, C | 1 |
| Brickley, X; Duval, J; Legrand, P; Orsoni, A; Soussy, CJ | 1 |
| Lamothe, F; Malouin, F | 1 |
| Beskid, G; Durkin, JW; Fallat, V; Lipschitz, ER; McGarry, DH; Siebelist, J | 1 |
| Andrew, JH; Downes, J | 1 |
| Arai, S; Hayashi, S; Kobayashi, S; Sakaguchi, T | 1 |
| Friese, S; Loriaux, SM; Pricker, GJ; Willems, FT | 1 |
| Roselle, GA | 1 |
| Lauderdale, BL; Washington, JA; Yu, PK | 1 |
| Jimenez-Valera, M; Ramos-Cormenzana, A; Ruiz-Bravo, A | 1 |
| Barry, AL; Fuchs, PC; Jones, RN | 1 |
| Cullmann, W; Dick, W | 1 |
| Cullmann, W; Seibert, G | 1 |
| Brumfitt, W; Franklin, I; Grady, D; Hamilton-Miller, JM | 1 |
| Inoue, M; Kakizawa, H; Minami, S; Mitsuhashi, S; Saikawa, I; Takai, A; Yasuda, T; Yotsuji, A | 1 |
| Elson, S; Southgate, R | 1 |
| Cole, M | 1 |
| Fu, KP; Neu, HC | 1 |
| Frère, JM; Ghuysen, JM; Kelly, JA; Klein, D | 1 |
| Baumgärtner, M; Müller, HP; Wundt, W | 1 |
| Baumgärtner, M | 1 |
| Li, JT; Yang, YJ | 1 |
| Bennett, SA; Dent, J; Wise, R | 1 |
| Maskell, JP; Nasu, M; Williams, JD | 1 |
| Auger, F; Lacroix, JM; Lamothe, F | 1 |
| Bebear, C; de Barbeyrac, B; Quentin, C | 1 |
| Rogers, DT; Russell, AD | 1 |
| O'Grady, FW | 1 |
| Aoki, H; Okuhara, M | 1 |
| Chen, HY; Livermore, DM; Yuan, M | 1 |
| Harris, EB; Hastings, RC; Prabhakaran, K; Randhawa, B | 1 |
| Pichichero, ME | 1 |
| Bush, K; Lee, VJ; Macalintal, C; Rasmussen, BA; Yang, Y | 1 |
| Aznar, MP; Cañas, JM; Gimeno, LA; Guillén, A; Pérez Caballero, MC; Sánchez Celaya, M | 1 |
| Anderson, G; Boldiston, C; O'Brien, P; Woods, S | 1 |
| Brook, I | 1 |
| Aleo, G; Blandino, G; Caccamo, F; Nicolosi, VM; Siracusa, V; Speciale, A | 1 |
| Alonso, JM; Fournier, JL; Jacolot, AC; Petitjean, OJ; Ramisse, F; Scavizzi, MR; Szatanik, M | 1 |
| Alós, JI; Balas, D; Cogollos, R; Gomez-Graces, JL; Tajada, P | 1 |
| Bauernfeind, A | 1 |
| Livermore, DM; Yuan, M | 1 |
| Lee, SK; Ng, AW; Oh, HM | 1 |
| Knapp, CC; Ludwig, MD; Pohlman, JK; Washington, JA | 1 |
| Albrecht, H; Bubert, A; Elsner, HA; Laufs, R; Mack, D; Sobottka, I | 1 |
| Blumer, JL; Bonafede, ME | 1 |
| Bezbaruah, RL; Ghosh, AC; Paul, S; Roy, MK | 1 |
| Adler, M; Keyserling, C; McDonald, PJ; Tack, K; Trostmann, U | 1 |
| Hanaki, H; Nagayama, A; Nomura, S | 1 |
| Gallés, C; Gasós, MA; Sauca, G | 1 |
| Bajaksouzian, S; Jacobs, MR | 1 |
| Constantoulaki, S; Paniara, O; Platsouka, E; Zissis, NP | 1 |
| García Iriarte, M; García Monge, E; Gómez Angel, D; O'Connor Reina, C | 1 |
| Amicosante, G; Cornaglia, G; Franceschini, N; Mazzariol, A; Perilli, M; Segatore, B; Setacci, D | 1 |
| Guest, N; Langan, CE | 1 |
| Esparcia Navarro, M; García Callejo, FJ; Orts Alborch, MH; Pardo Mateu, L; Velert Vila, MM | 1 |
| García-Rodríguez, JA | 1 |
| Perret, JL; Thibault, F; Vidal, D | 1 |
| Alberty, J; Hermann, W; Stoll, W | 1 |
| Bao, D; Fan, X; Liu, B; Zhou, L | 1 |
| Hadziyannis, E; Hall, GS; Procop, GW; Thomas, L; Tuohy, M; Washington, JA | 1 |
| Barrio, JL; Dedéu, JM; Gómez, C; Guarner, C; Kolle, L; Miñana, J; Novella, MT; Ortiz, J; Ricart, E; Sàbat, M; Sola-Vera, J; Soriano, G | 1 |
| de Sá Del Fiol, F; Groppo, FC; Rocha De Mattos Filho, T | 1 |
| Birkenhead, D; Chanawong, A; Hawkey, PM; Kerr, KG; M'Zali, FH | 1 |
| Dimopoulou, H; Miriagou, V; Platsouka, E; Tzelepi, E; Tzouvelekis, LS | 1 |
| Bégué, CR; Bégué, RE; English, MR; Perez Mato, S | 1 |
| Louie, M; Simor, AE; Watt, C | 1 |
| Lloyd, MD; Prescott, AG | 1 |
| Carter, MW; Livermore, DM; Oakton, KJ; Warner, M | 1 |
| Amicosante, G; Belloni, R; Bianchi, C; Lombardi, G; Luzzaro, F; Perilli, M; Toniolo, A; Zollo, A | 1 |
| Arr, M; Flautner, L; Pulay, I; Williams, C; Zsirka, KA | 1 |
| François, M | 1 |
| Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
| Bellais, S; Naas, T; Nordmann, P | 1 |
| Elander, RP | 1 |
| Baize, T; Fleming, DR; Goldsmith, GH; Herzig, RH; Mudd, L; Ziegler, C | 1 |
| Mayayo Dehesa, T; Navas Elorza, E; Quereda Rodríguez-Navarro, C; Rodríguez-Patrón Rodríguez, R | 1 |
| Biddle, JW; Fridkin, SK; Jevitt, L; McGowan, JE; Oliver, A; Raney, PM; Rasheed, JK; Tenover, FC; Williams, PP | 1 |
| Jamieson, CE; Lambert, PA; Simpson, IN | 1 |
| Avesani, V; Berhin, C; De Gheldre, Y; Delmée, M; Glupczynski, Y | 1 |
| Babić-Erceg, A; Barisić, Z; Borzić, E; Carev, M; Kaliterna, V; Zoranić, V | 1 |
| Bell, JM; Jones, RN; Turnidge, JD | 1 |
| Høiby, N; Walther-Rasmussen, J | 1 |
| Chuang, CL; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
| Laufs, R; Mack, D; Noor, D; Sobottka, I; Stürenburg, E | 1 |
| Bonnefoy, A; Delachaume, C; Dupuis-Hamelin, C; Fairley, M; Guitton, M; Lampilas, M; Seys, C; Stachyra, T; Steier, V | 1 |
| Agrawal, M; Malik, A; Shahid, M; Singhal, S | 1 |
| Ben Meriem, C; Ghedira Besbes, L; Guediche, MN; Messaoudi, A | 1 |
| Greenberg, D; Leibovitz, E | 1 |
| Mammeri, H; Nordmann, P; Poirel, L | 1 |
| Shmelev, EI | 1 |
| Kardas, P; Muras, M | 1 |
| Arora, S; Bal, M | 1 |
| Akova, M; Hasçelik, G; Metan, G; Zarakolu, P | 1 |
| Mazereeuw-Hautier, J | 1 |
| Bilewska, A; Dukaczewska, A; Goławski, C; Kicman, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J; Serafin, I | 1 |
| Angamuthu, KK; Kader, AA; Kamath, KA; Zaman, MN | 1 |
| Caniça, M; Ferreira, E; Mendonça, N | 1 |
| Bonten, MJ; Buskens, E; Hoepelman, AI; Hustinx, WM; Kaasjager, K; Kramer, MH; Lammers, JW; Oosterheert, JJ; Prins, JM; Schneider, MM; Slee, PH | 1 |
| Cogo, LL; Dalla Costa, LM; de Oliveira, S; de Souza, HA; do Nascimento, AJ; Higuti, IH; Matos, AP; Nogueira, Kda S; Terasawa, LB | 1 |
| Ge, Y; Kaniga, K; Livermore, DM; Mushtaq, S; Warner, M | 1 |
| Coati, N; Passmore, CA; Sherington, J; Stegemann, MR | 1 |
| Andrews, J; Brenwald, N; Fraise, A; Jain, S | 1 |
| Passmore, C; Sherington, J; Stegemann, MR | 1 |
| Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J | 1 |
| Chen, G; Hu, ZQ; Ito, R; Shimamura, T; Zhao, WH | 1 |
| Brossier, F; Drieux, L; Jarlier, V; Sougakoff, W | 1 |
| Hope, R; Livermore, DM; Mushtaq, S; Warner, M | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Asseray, N; Bleher, Y; Boutoille, D; Bretonniere, C; Hoff, J; Lombrail, P; Poirier, Y; Potel, G | 1 |
| Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L | 1 |
| Adamsson, L; Dornbusch, K; Hallander, HO | 1 |
| Herrera, M; Jorgensen, JH; Lewis, JS; Towne, TG; Wickes, B | 1 |
| Deb, M; Gaind, R; Mohanty, S; Ranjan, R | 1 |
| Carrascal-Camacho, AK; Mattar, S; Neuque-Rico, MC; Poutou-Piñales, RA; Ruiz-Bolivar, Z | 1 |
| Beceiro, A; Bou, G; Dhanji, H; Doumith, M; Downie, G; Doyle, M; Gaulton, T; Hickey, M; Livermore, DM; Maharjan, S; Soares, NC; Warner, M; Woodford, N | 1 |
| Cercenado, E; de Toro, M; García-Campello, M; Rojo-Bezares, B; Sáenz, Y; Torres, C; Undabeitia, E | 1 |
| Campbell, JD; Fulcher, LC; Jorgensen, JH; Lewis, JS; McElmeel, ML | 1 |
| Ahmad, B; Ahmad, M; Aziz, MT; Hameed, H; Hussain, Y; Naseem, A | 1 |
| Dai, X; Gao, Q; Li, J; Xiang, S; Yang, K | 1 |
| Bidet, P; Bingen, E; Birgy, A; Cohen, R; Mariani, P; Sobral, E | 1 |
| Arthur, M; Dubée, V; Dubost, L; Ethève-Quelquejeu, M; Gutmann, L; Hugonnet, JE; Mainardi, JL; Marie, A; Triboulet, S | 1 |
| Conklin, BC; Hutton, RA; Li, M; Skalweit, MJ; Taracila, MA | 1 |
| Ducho, C; Gomez-Castellanos, JR; Hamed, RB; Henry, L; McDonough, MA; Schofield, CJ | 1 |
| Bakthavatchalu, S; Mishra, T; Shakthivel, U | 1 |
| Andersson, I; Blikstad, C; Demetriades, M; Dubus, A; Généreux, C; Hopkinson, RJ; Iqbal, A; Ivison, D; Kershaw, NJ; Lloyd, AJ; McDonough, MA; Roper, DI; Schofield, CJ; Valegård, K | 1 |
| Aubert, V; Baserni, MN; Jugo, MB; Villar, HE | 1 |
| Hauk, L | 1 |
| Chang, EK; Huang, YT; Kao, KL; Liao, CH; Liu, CY; Tsai, MS; Yang, CJ | 1 |
| Ardıç, N; Duyan, S; Kılıç, A; Yılmaz, S | 1 |
| Boyd, D; Carpenter, M; Desruisseau, A; Janecko, N; Mangat, CS; Martz, SL; Mulvey, MR; Reid-Smith, RJ | 1 |
| Cicek, AC; Duzgun, AO; June, CM; Leonard, DA; Sandalli, C; Saral, A | 1 |
| Bhandari, R; Pant, ND; Poudel, A; Sharma, M | 1 |
| Baumert, P; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Knobloch, J; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, A; Seifert, H; Tacconelli, E; Willmann, M | 1 |
| Arthur, M; Ourghanlian, C; Soroka, D | 1 |
| Bell, DT; Chauhan, V; Kaushik, A; Kumar, P; Lamichhane, G; Stevens, RL; Xia, F | 1 |
| Chan, KF; Chen, T; He, Y; Pan, X; Zhao, Y | 1 |
| Agunos, A; Caffrey, N; Checkley, S; Gow, S; Nekouei, O | 1 |
| Batard, E; Caillon, J; Chapelet, G; Javaudin, F; Marquet, A; Montassier, E; Vibet, MA | 1 |
| Sharma, AK; Vats, P | 1 |
| Ahmadvand, P; Avillan, JJ; Call, DR; Kang, C; Lewis, JA | 1 |
| Abu-Raideh, J; Al-Tamimi, M; Albalawi, H; Alhaj, F; Khasawneh, AI; Shalabi, M | 1 |
| Antonelli, A; Cherubini, S; D'Andrea, MM; Perilli, M; Piccirilli, A; Rossolini, GM | 1 |
| Bandić-Pavlović, D; Barišić, I; Beader, N; Bedenić, B; Frančula-Zaninović, S; Krilanović, M; Pešorda, L; Schoenthaler, S; Veir, Z | 1 |
| Acampora, A; Albano, R; Buonsenso, D; Ferrari, V; Fiori, B; Pata, D; Sanguinetti, M; Spanu, T; Valentini, P | 1 |
| Amato, HK; Garcia, D; Graham, JP; Johnson, TJ; Loayza, F; Paredes, D; Pickering, AJ; Riley, LW; Salinas, L; Saraiva-Garcia, C; Sarzosa, S; Trueba, G | 1 |
17 review(s) available for cephalosporin c and clavulanic acid
| Article | Year |
|---|---|
New considerations in treatment of urinary tract infections in adults.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Cystitis; Female; Humans; Male; Pyelonephritis; Quinolones; Recurrence; Urinary Tract Infections | 1992 |
Treatment of uncomplicated infections due to Neisseria gonorrhoeae. A review of clinical efficacy and in vitro susceptibility studies from 1982 through 1985.
Topics: Cephalosporins; Chlamydia Infections; Clavulanic Acid; Clavulanic Acids; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillanic Acid; Penicillin Resistance; Penicillins; Pharyngeal Diseases; Quinolines; Spectinomycin; Sulbactam; Syphilis; Tetracycline | 1986 |
Naturally occurring beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Lactams; Penicillins; Thienamycins | 1985 |
Natural beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Clavulanic Acid; Lactams; Penicillins; Thienamycins | 1980 |
Assessing the treatment alternatives for acute otitis media.
Topics: Acute Disease; Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Humans; Infant; Otitis Media; Patient Compliance; Prescription Fees; Remission, Spontaneous | 1994 |
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Molecular Structure; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin | 1996 |
[Pulmonary melioidosis].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Chloramphenicol; Clavulanic Acid; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Humans; Melioidosis; Penicillins; Pneumonia, Bacterial; Radiography, Thoracic; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Drug-resistant Streptococcus pneumoniae spinal epidural abscess in a toddler.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Cefotaxime; Cephalosporins; Child, Preschool; Clavulanic Acid; Drug Resistance, Microbial; Epidural Abscess; Humans; Male; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
The iron(II) and 2-oxoacid-dependent dioxygenases and their role in metabolism.
Topics: Alkaloids; Carnitine; Cephalosporins; Cephamycins; Clavulanic Acid; Ethylenes; Hydroxylation; Iron; Oxygenases; Penicillins; Sulfates | 2000 |
Industrial production of beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Biotechnology; Carbapenems; Cephalosporins; Cephamycins; Clavulanic Acid; Drug Industry; Fermentation; Penicillins | 2003 |
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enzyme Inhibitors; Gene Transfer, Horizontal; Monobactams; Penicillanic Acid; Penicillins; Phylogeny; Sulbactam; Tazobactam | 2004 |
Acute otitis media in children: current epidemiology, microbiology, clinical manifestations, and treatment.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Bacterial Vaccines; Cephalosporins; Child; Clavulanic Acid; Humans; Otitis Media; Quinolones; Streptococcus pneumoniae; Sulfonamides | 2004 |
[Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
Topics: Administration, Oral; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Injections, Intravenous; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Time Factors | 2004 |
[Impetigo].
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Azithromycin; Cephalosporins; Child; Clavulanic Acid; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin; Mupirocin; Ointments; Penicillins; Pregnancy; Pristinamycin; Sulfadiazine; Time Factors | 2006 |
Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity | 2008 |
Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2008 |
The enzymes of β-lactam biosynthesis.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Humans; Mitosporic Fungi; Molecular Structure; Penicillins | 2013 |
13 trial(s) available for cephalosporin c and clavulanic acid
| Article | Year |
|---|---|
Single-dose prophylaxis in gynaecological surgery: amoxycillin/clavulanic acid versus the combination of cefuroxim and metronidazole in a randomized prospective comparison.
Topics: Adult; Aged; Amoxicillin; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Metronidazole; Middle Aged; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection; Urinary Tract Infections | 1988 |
A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Cost-Benefit Analysis; Gastrointestinal Diseases; Humans; Penicillins; Prospective Studies; Surgical Wound Infection; Ticarcillin | 1996 |
Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Treatment Outcome | 1996 |
Cefdinir versus amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Diarrhea; Female; Humans; Infant; Male; Otitis Media, Suppurative; Penicillins | 1997 |
Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Amoxicillin; Bronchitis; Ceftibuten; Cephalosporins; Chronic Disease; Clavulanic Acid; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Treatment Outcome | 1998 |
[Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Clavulanic Acid; Female; Humans; Male; Maxillary Sinusitis; Otitis Media; Penicillins; Pharyngitis; Tonsillitis | 1998 |
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Penicillins; Treatment Outcome | 2000 |
[Antibiotic prophylaxis for high risk patients undergoing cholecystectomy].
Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefamandole; Cefotaxime; Cefuroxime; Cephalosporins; Cholecystectomy; Clavulanic Acid; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Penicillins; Postoperative Complications; Reoperation; Risk; Risk Factors; Surgical Wound Infection; Treatment Outcome | 2000 |
Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Aztreonam; Cefepime; Cephalosporins; Clavulanic Acid; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever; Humans; Immunocompromised Host; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Ticarcillin | 2003 |
Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Combinations; Humans; Infusions, Intravenous; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome | 2006 |
Clinical efficacy and safety of cefovecin in the treatment of canine pyoderma and wound infections.
Topics: Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acid; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Male; Pyoderma; Treatment Outcome; Wound Infection | 2007 |
The efficacy and safety of cefovecin in the treatment of feline abscesses and infected wounds.
Topics: Abscess; Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Clavulanic Acid; Europe; Female; Injections, Subcutaneous; Male; Treatment Outcome; Wound Infection | 2007 |
A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Drug Therapy, Combination; Female; Fever; Humans; Infant; Infant, Newborn; Lymphoma; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Treatment Outcome; Young Adult | 2011 |
129 other study(ies) available for cephalosporin c and clavulanic acid
| Article | Year |
|---|---|
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; Carrier Proteins; Cefpirome; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Synergism; Hexosyltransferases; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus; Sulbactam | 1992 |
In vitro activities of Ro 40-6890 against 164 predominantly intestinal members of the families Enterobacteriaceae and Vibrionaceae.
Topics: Amoxicillin; Cefadroxil; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Intestines; Microbial Sensitivity Tests; Vibrionaceae | 1992 |
[Identification of a new penicillinase in a Klebsiella pneumoniae strain of which a mutant also produces an esterase hydrolyzing cephalothin and cefotaxime].
Topics: Acetylesterase; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Penicillin Resistance; Penicillinase; Penicillins | 1992 |
Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Molecular Weight; Penicillanic Acid; Penicillin Resistance; Penicillins; Pseudomonas; Sulbactam; Tazobactam | 1991 |
A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Humans; Microbial Sensitivity Tests; Sulbactam | 1991 |
In vitro activity of BAY v 3522, a new oral cephalosporin.
Topics: Administration, Oral; Amoxicillin; Bacteria; Benzothiazoles; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Pasteurella; Streptococcus pneumoniae; Streptococcus pyogenes | 1990 |
Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Conjugation, Genetic; Drug Resistance, Microbial; Escherichia coli; Humans; Hydrolysis; Infant, Newborn; Klebsiella; Penicillins; Plasmids | 1990 |
In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Topics: Ampicillin; Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillins; Sulbactam; Ticarcillin | 1990 |
In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
Topics: beta-Lactamases; Carbapenems; Cephalosporinase; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Escherichia coli; Klebsiella; Microbial Sensitivity Tests | 1989 |
A decade of PPNG in Singapore.
Topics: Cephalosporins; Clavulanic Acid; Clavulanic Acids; Female; Gonorrhea; Humans; Kanamycin; Male; Neisseria gonorrhoeae; Penicillin Resistance; Penicillinase; Penicillins; Sex Factors; Sex Work; Singapore; Spectinomycin | 1987 |
The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcus aureus; Sulbactam | 1986 |
[Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cephalosporins; Citrobacter; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Imipenem; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 1988 |
The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group.
Topics: Bacteroides; Bacteroides fragilis; beta-Lactamases; Cefamandole; Cefoxitin; Cell Membrane Permeability; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Edetic Acid; Species Specificity | 1987 |
In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
Topics: Acinetobacter; Amoxicillin; Bacteria; Cefaclor; Cefmenoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1987 |
Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillins; Ticarcillin | 1988 |
Simple assay of beta-lactamase with agar medium containing a chromogenic cephalosporin, pyridinium-2-azo-p-dimethylaniline chromophore (PADAC).
Topics: Agar; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chromogenic Compounds; Clavulanic Acid; Clavulanic Acids; Enterobacter; Hydrolysis | 1988 |
Nosocomial and nursing home-acquired pneumonia. Recent therapeutic advances.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cilastatin; Clavulanic Acid; Clavulanic Acids; Cross Infection; Cyclopropanes; Humans; Imipenem; Nursing Homes; Pneumonia; Thienamycins; Ticarcillin | 1987 |
In vitro activity of an orally administered cephalosporin, LY164846, against potentially pathogenic respiratory and dermal bacterial isolates.
Topics: Amoxicillin; Cephalexin; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Combinations; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Respiratory System; Skin; Staphylococcus aureus; Time Factors | 1986 |
Synergistic effects of dicloxacillin or clavulanic acid in combination with penicillin G or cephalothin against Yersinia enterocolitica.
Topics: beta-Lactamase Inhibitors; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Dicloxacillin; Drug Synergism; Microbial Sensitivity Tests; Penicillin G; Yersinia enterocolitica | 1986 |
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Topics: Bacteria, Aerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Sulbactam | 1987 |
[A simple enzyme assay for the simultaneous determination of penicillin derivatives and clavulanic acid in biological fluids].
Topics: beta-Lactamases; Binding, Competitive; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Clinical Enzyme Tests; Humans; Penicillins; Proteus vulgaris | 1986 |
Properties of an inducible beta-lactamase from Proteus vulgaris.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chloromercuribenzoates; Chromatography; Clavulanic Acid; Clavulanic Acids; Electrophoresis, Polyacrylamide Gel; p-Chloromercuribenzoic Acid; Penicillins; Proteus vulgaris; Substrate Specificity | 1986 |
Effect of amoxicillin-clavulanate and cephradine on the fecal flora of healthy volunteers not exposed to a hospital environment.
Topics: Amoxicillin; Bacteria; Cephalosporins; Cephradine; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Feces; Female; Humans; Male | 1986 |
Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cephamycins; Clavulanic Acid; Clavulanic Acids; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillin G | 1985 |
'Beta-lactams' as beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Drug Evaluation, Preclinical; Drug Synergism; Lactams; Penicillins | 1980 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
Interaction between non-classical beta-lactam compounds and the Zn2+-containing G and serine R61 and R39 D-alanyl-D-alanine peptidases.
Topics: Actinomycetaceae; Amdinocillin; beta-Lactams; Carboxypeptidases; Cefoxitin; Cephalosporins; Clavulanic Acid; Drug Interactions; Endopeptidases; Enzyme Inhibitors; Imipenem; Kinetics; Penicillanic Acid; Penicillins; Quinoxalines; Serine-Type D-Ala-D-Ala Carboxypeptidase; Streptomyces; Zinc | 1981 |
[Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefsulodin; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Netilmicin; Penicillanic Acid; Sulbactam | 1983 |
[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
Topics: beta-Lactamase Inhibitors; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 1983 |
A study of antibacterial activity of furbenicillin against beta-lactamase producing gram-negative organisms.
Topics: Ampicillin; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillins | 1984 |
The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid.
Topics: Adult; Amoxicillin; Blister; Body Fluids; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Feces; Humans; Intestinal Absorption; Kinetics; Male | 1984 |
Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial | 1984 |
Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Indicators and Reagents; Microbial Sensitivity Tests | 1984 |
[Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
Topics: Bacteroides fragilis; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Metronidazole; Penicillins; Ticarcillin | 1984 |
Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enzyme Inhibitors; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1980 |
Twenty-one years of beating beta-lactamases.
Topics: Amoxicillin; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Humans; Penicillin Resistance | 1982 |
Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.
Topics: beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Cloxacillin; Enzyme Inhibitors; Humans; Indicators and Reagents; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa | 1995 |
beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cell Division; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Penicillanic Acid; Streptomycin; Sulbactam; Tazobactam | 1995 |
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Hydrolysis; Isoelectric Focusing; Kinetics; Molecular Weight; Penicillanic Acid; Spectrophotometry, Ultraviolet; Tazobactam | 1993 |
[Prescription of antibiotics in acute respiratory infections].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Prescriptions; Drug Therapy, Combination; Expectorants; Humans; Macrolides; Penicillins; Respiratory Tract Infections | 1996 |
Treatment of aspiration or tracheostomy-associated pneumonia in neurologically impaired children: effect of antimicrobials effective against anaerobic bacteria.
Topics: Adolescent; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Clindamycin; Female; Fever; Humans; Male; Penicillins; Pneumonia, Aspiration; Pneumonia, Bacterial; Retrospective Studies; Seizures; Ticarcillin; Tracheostomy; Unconsciousness | 1996 |
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Penicillins; Sicily; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 1996 |
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia, Bacterial; Tazobactam; Ticarcillin | 1996 |
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Campylobacter coli; Campylobacter jejuni; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam | 1996 |
Antibiotic susceptibility patterns of respiratory isolates of Klebsiella pneumoniae in Europe and the USA in 1992 and 1993. The Alexander Project Collaborative Group.
Topics: 4-Quinolones; Amoxicillin; Anti-Infective Agents; Cephalosporins; Chloramphenicol; Chloramphenicol Resistance; Clavulanic Acid; Clavulanic Acids; Doxycycline; Drug Resistance, Microbial; Europe; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Respiratory Tract Infections; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 1996 |
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Piperacillin; Tazobactam | 1996 |
Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Therapy, Combination; Enterobacter cloacae; Enzyme Inhibitors; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Tazobactam; Ticarcillin; Time Factors | 1996 |
Catalase-negative Listeria monocytogenes causing lethal sepsis and meningitis in an adult hematologic patient.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Blotting, Western; Catalase; Ceftriaxone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Diagnosis, Differential; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Female; Humans; Listeria monocytogenes; Lymphoma, T-Cell, Cutaneous; Meningitis, Listeria; Penicillins; Polymerase Chain Reaction; Sepsis; Tobramycin | 1996 |
Multiple antibiotic resistance (MAR) index and its reversion in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1997 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
[Changes in the sensitivity of Escherichia coli to 6 antimicrobial agents during the last 12 years. Group of Microbiologists of County Hospitals of Catalonia].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Spain; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Culture Media; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Osmolar Concentration; Penicillins | 1997 |
Comparative in vitro evaluation of piperacillin/tazobactam in a tertiary care hospital.
Topics: Amoxicillin; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Tazobactam | 1997 |
[Complications of sinusitis].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Ceftriaxone; Cephalosporins; Clavulanic Acid; Drug Therapy, Combination; Expectorants; Female; Humans; Male; Methylprednisolone; Metronidazole; Middle Aged; Penicillins; Primary Health Care; Sinusitis; Time Factors; Vasoconstrictor Agents | 1998 |
Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Interactions; Drug Resistance, Multiple; Enzyme Inhibitors; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Penicillanic Acid; Providencia; Sulbactam; Tazobactam | 1998 |
Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Humans; Penicillins; Spain; Urinary Tract Infections | 1998 |
[Interesting case no. 25. Cervical tuberculous lymphadenitis].
Topics: Adult; Amoxicillin; Cefotaxime; Cephalosporins; Clavulanic Acid; Clindamycin; Diagnostic Techniques, Surgical; Drug Combinations; Humans; Male; Tuberculosis, Lymph Node | 1999 |
[Study on the beta-lactamases of the Escherichia coli HX88108 resistant to ceforperazon].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Hydrolysis; Sulbactam | 1998 |
Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Clavulanic Acid; Escherichia coli; Humans; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype | 2000 |
Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Ceftriaxone; Cephalexin; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Disease Models, Animal; Drug Therapy, Combination; Male; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcus aureus | 2000 |
Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Genes, Bacterial; Microbial Sensitivity Tests; Reverse Transcriptase Polymerase Chain Reaction | 2000 |
Diversity of beta-lactam resistance levels among related Klebsiella pneumoniae strains isolated in an intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Cross Infection; Disease Outbreaks; Drug Therapy, Combination; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2000 |
Evaluation of stability of cefotaxime (30-microg) and ceftazidime (30-microg) disks impregnated with clavulanic acid (10 microg) for detection of extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Stability; Escherichia coli; Evaluation Studies as Topic; Microbial Sensitivity Tests; Time Factors | 2000 |
Detection of extended-spectrum beta-lactamases in klebsiellae with the Oxoid combination disk method.
Topics: Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftazidime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2000 |
Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Proteus Infections; Proteus mirabilis; Tazobactam | 2001 |
[Treatment of acute otitis media in children].
Topics: Acute Disease; Age Factors; Amoxicillin; Analgesics; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Child, Preschool; Clavulanic Acid; Conjunctivitis; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Otitis Media; Penicillins; Risk Factors | 1998 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |
Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Conjugation, Genetic; Enzyme Induction; Escherichia coli; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Recombinant Proteins | 2002 |
[Meningitis caused by multiresistant E. coli after an echo-directed transrectal biopsy].
Topics: Aged; Amoxicillin; Biopsy; Brain Damage, Chronic; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Confusion; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Male; Meningitis, Bacterial; Premedication; Prostate; Rectum; Ultrasonography; Vancomycin | 2003 |
Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Clavulanic Acid; Escherichia coli; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity | 2003 |
In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Synergism; Enterococcus faecalis; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Lactams; Microbial Sensitivity Tests; Staphylococcus aureus | 2003 |
Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases.
Topics: beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Evaluation, Preclinical; Drug Therapy, Combination; Genotype; Humans; Microbial Sensitivity Tests | 2003 |
Urinary tract infections in South Croatia: aetiology and antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acid; Croatia; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Nitrofurantoin; Norfloxacin; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2003 |
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.
Topics: Asia; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Pacific Islands; Penicillins; Phenotype; South Africa | 2003 |
Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-beta-lactamases in gram-negative bacilli.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acid; Culture Media, Conditioned; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 2004 |
Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella oxytoca; Phenotype | 2004 |
In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor.
Topics: Azepines; Bacteria; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Dealkylation; Enzyme Inhibitors; Escherichia coli; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Sulfuric Acid Esters; Tazobactam | 2004 |
Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test.
Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Ceftazidime; Cephalosporins; Cephamycins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Klebsiella pneumoniae; Phenotype; Pseudomonas aeruginosa | 2004 |
[Treatment mostly not in line with current knowledge. New guidelines for sinusitis therapy].
Topics: Acute Disease; Bacterial Infections; Ceftibuten; Cephalosporins; Chronic Disease; Clavulanic Acid; Drug Resistance, Multiple; Humans; Mometasone Furoate; Penicillanic Acid; Pregnadienediols; Sinusitis; Treatment Outcome | 2004 |
[Profile of antimicrobial resistance of agents causing urinary tract infections in children].
Topics: Adolescent; Age Factors; Aminoglycosides; Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Cephalosporin Resistance; Cephalosporins; Cephalothin; Child; Child, Preschool; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Infant; Klebsiella pneumoniae; Male; Penicillin Resistance; Proteus mirabilis; Retrospective Studies; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2004 |
TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
Topics: beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Cloning, Molecular; DNA, Bacterial; Enterobacter aerogenes; Enzyme Inhibitors; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial | 2004 |
[A blinded comparison of palatability of 13 common pediatric antibiotic suspensions].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Clavulanic Acid; Clindamycin; Double-Blind Method; Female; Humans; Male; Patient Compliance; Pediatrics; Penicillins; Respiratory Tract Infections; Suspensions; Taste; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
AmpC beta-lactamase producing bacterial isolates from Kolkata hospital.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Cefoxitin; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Induction; Hospitals; Humans; India; Isoelectric Focusing; Microbial Sensitivity Tests; Species Specificity | 2005 |
[Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Sensitivity and Specificity | 2005 |
[High effectiveness of the method with cefpirome in detection of extended-spectrum beta-lactamases in different species of gram-negative bacilli].
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cefpirome; Cephalosporins; Clavulanic Acid; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Species Specificity | 2006 |
Modified double-disc test for detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2006 |
Occurrence of a novel SHV-type enzyme (SHV-55) among isolates of Klebsiella pneumoniae from Portuguese origin in a comparison study for extended-spectrum beta-lactamase-producing evaluation.
Topics: Base Sequence; beta-Lactamases; Cephalosporins; Clavulanic Acid; Genes, Bacterial; Guidelines as Topic; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Portugal; Random Allocation; Sensitivity and Specificity | 2006 |
Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Brazil; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Hospitals, University; Humans; Microbial Sensitivity Tests | 2006 |
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Bacteroides; beta-Lactamases; Ceftaroline; Cephalosporins; Clavulanic Acid; Conjugation, Genetic; Drug Combinations; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Escherichia coli; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Phenotype; Respiratory Tract Diseases; Staphylococcus | 2007 |
Rapid detection of extended-spectrum beta-lactamase-producing Gram-negative bacilli in blood cultures.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Blood; Cephalosporins; Clavulanic Acid; Color; Culture Media; Enzyme Inhibitors; False Positive Reactions; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hydrolysis | 2007 |
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam | 2007 |
Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Conjugation, Genetic; Escherichia coli; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Penicillins; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
[Use of antibiotics in emergency units: qualitative and quantitative assessment].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Clavulanic Acid; Drug Therapy, Combination; Emergency Service, Hospital; Fluoroquinolones; France; Hospitals, Teaching; Humans; Middle Aged; Penicillins; Practice Guidelines as Topic; Young Adult | 2009 |
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins | 2009 |
Influence of bacterial beta-lactamase production on susceptibility in agar or broth to new cephalosporins.
Topics: Agar; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Culture Media; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1981 |
Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Enterobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2010 |
Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus mirabilis; Sensitivity and Specificity | 2009 |
Antimicrobial susceptibility of Listeria monocytogenes food isolates from different cities in Colombia.
Topics: Amoxicillin; Ampicillin; Cephalosporins; Chloramphenicol; Clavulanic Acid; Colombia; Drug Resistance, Bacterial; Drug Resistance, Multiple; Food Microbiology; Listeria monocytogenes; Microbial Sensitivity Tests | 2011 |
False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cefepime; Cefpirome; Cephalosporins; Clavulanic Acid; DNA; DNA, Recombinant; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Isoelectric Focusing; Microbial Sensitivity Tests; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transformation, Bacterial | 2011 |
Genetic characterization of the mechanisms of resistance to amoxicillin/clavulanate and third-generation cephalosporins in Salmonella enterica from three Spanish hospitals.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Clavulanic Acid; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Salmonella enterica; Salmonella Infections; Spain | 2011 |
Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests | 2012 |
Development of a colorimetric assay for rapid quantitative measurement of clavulanic acid in microbial samples.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chromatography, High Pressure Liquid; Clavulanic Acid; Colorimetry; Culture Media, Conditioned; Mutation; Reproducibility of Results; Streptomyces | 2012 |
In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-beta-lactamase-producing Escherichia coli causing urinary tract infection.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Enzyme Inhibitors; Humans | 2012 |
Inactivation of Mycobacterium tuberculosis l,d-transpeptidase LdtMt₁ by carbapenems and cephalosporins.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clavulanic Acid; Extensively Drug-Resistant Tuberculosis; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peptidoglycan; Peptidyl Transferases; Thienamycins | 2012 |
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.
Topics: Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Biocatalysis; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Kinetics; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutagenesis, Site-Directed; Structure-Activity Relationship; Substrate Specificity; Sulbactam; Thienamycins | 2012 |
Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Body Fluids; Boronic Acids; Cefepime; Cefoxitin; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Substrate Specificity | 2013 |
Structural and mechanistic studies of the orf12 gene product from the clavulanic acid biosynthesis pathway.
Topics: Amino Acid Motifs; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carboxypeptidases; Catalytic Domain; Cephalosporins; Clavulanic Acid; Crystallography, X-Ray; Hydrolysis; Models, Molecular; Penicillins; Protein Conformation; Protein Structure, Tertiary; Serine; Streptomyces | 2013 |
Maternal carriage of extended-spectrum beta-lactamase-producing Escherichia coli isolates in Argentina.
Topics: Anti-Bacterial Agents; Argentina; beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Gestational Age; Humans; Maternal Exposure; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vagina | 2013 |
AAP releases guideline on diagnosis and management of acute bacterial sinusitis in children one to 18 years of age.
Topics: Academies and Institutes; Acute Disease; Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Humans; Infant; Pediatrics; Sinusitis | 2014 |
Occult Klebsiella pneumoniae bacteremia at emergency department: A single center experience.
Topics: Amoxicillin; Anti-Bacterial Agents; Asymptomatic Diseases; Bacteremia; Cephalosporins; Clavulanic Acid; Emergency Service, Hospital; Female; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Patient Discharge; Retrospective Studies; Taiwan | 2015 |
[Rapid detection of extended-spectrum beta-lactamases by flow cytometry method].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Combinations; Enterobacteriaceae; Flow Cytometry; Humans | 2015 |
Characterization of VCC-1, a Novel Ambler Class A Carbapenemase from Vibrio cholerae Isolated from Imported Retail Shrimp Sold in Canada.
Topics: Amino Acid Sequence; Animals; Aztreonam; Bacterial Proteins; Base Sequence; beta-Lactamases; Canada; Carbapenems; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Penaeidae; Penicillanic Acid; Penicillins; Seafood; Sequence Alignment; Sequence Analysis, DNA; Tazobactam; Vibrio cholerae | 2016 |
Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Hydrolysis; Mutation; Penicillins; Plasmids; Protein Conformation; Substrate Specificity; Turkey | 2016 |
Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, N
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clinical Laboratory Services; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Nepal; Phenotype; Public Health; Reproducibility of Results; Treatment Outcome; Urine | 2016 |
Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Germany; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Tazobactam; Young Adult | 2017 |
Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N
Topics: Amino Acid Motifs; Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Clavulanic Acid; Cloning, Molecular; Drug Combinations; Escherichia coli; Gene Expression; Kinetics; Mutation; Recombinant Proteins; Reverse Genetics; Substrate Specificity | 2017 |
Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; Cephalosporins; Clavulanic Acid; DNA, Intergenic; Gene Expression; Genetic Loci; Humans; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Protein Binding; Thienamycins; Tuberculosis, Multidrug-Resistant | 2017 |
Modified Penicillin Molecule with Carbapenem-Like Stereochemistry Specifically Inhibits Class C β-Lactamases.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Catalytic Domain; Cephalosporins; Clavulanic Acid; Crystallography, X-Ray; Models, Molecular; Molecular Structure; Penicillins; Stereoisomerism; Sulbenicillin | 2017 |
Risk factors associated with the A2C resistance pattern among E. coli isolates from broiler flocks in Canada.
Topics: Amoxicillin; Animal Husbandry; Animals; Anti-Bacterial Agents; Canada; Cefoxitin; Cephalosporins; Chickens; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Poultry Diseases; Risk Factors | 2017 |
Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Characterization of Interactions between CTX-M-15 and Clavulanic Acid, Desfuroylceftiofur, Ceftiofur, Ampicillin, and Nitrocefin.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Microbial Sensitivity Tests; Molecular Docking Simulation | 2022 |
Cefixime and cefixime-clavulanate for screening and confirmation of extended-spectrum beta-lactamases in Escherichia coli.
Topics: Adolescent; Adult; Aged; beta-Lactamases; Cefixime; Cephalosporins; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2022 |
Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases.
Topics: Bacterial Proteins; beta-Lactamases; Cephalosporins; Clavulanic Acid; Kinetics; Plasmids; Sulbactam; Tazobactam | 2022 |
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Colistin; Croatia; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Escherichia coli resistance patterns, empiric and targeted antibiotic prescriptions in children: a single center experience.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Infant; Microbial Sensitivity Tests; Prescriptions; Retrospective Studies | 2022 |
Risk factors for extended-spectrum beta-lactamase (ESBL)-producing E. coli carriage among children in a food animal-producing region of Ecuador: A repeated measures observational study.
Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Ceftazidime; Cephalosporins; Child; Clavulanic Acid; Dogs; Ecuador; Escherichia coli; Female; Humans; Male; Risk Factors; Swine | 2023 |